Manna Michael Edward

ULBI CEO Manna buys 2,000 shares at $6.47; stock down 35.9% from 52-week high; prior 5 trades at this ticker all well-timed on 90d basis.

CEO Michael Edward Manna purchased 2,000 shares of Ultralife at $6.47 on 2026-05-18, expanding his holdings from 26,674 to 28,674 shares. The purchase occurs as the stock trades -35.9% from its 52-week high and is down 21.1% over the last 30 days, creating a contrarian buying signal. Notably, Manna's prior 5 trades at Ultralife were all well-timed at the 90-day mark (with 90d returns ranging from +0.6% to +28.5%), suggesting a consistent pattern of purchasing at strategically favorable entry points. However, context matters: the company remains unprofitable (net income $-451,000 in the latest quarter despite $47.4M in revenue and 16.2% annual revenue growth), and the stock has declined 1.9% over 90 days, meaning this purchase occurs in a materially different environment than his prior successes at this ticker.

CEO Manna Michael Edward purchased 2,000 shares at $6.01 blended average on 2026-03-12, expanding stake to 26,874 shares.

Michael Edward, President and CEO of Ultralife Corp, executed 2 separate purchases totaling 2,000 shares for $12,024.20, expanding his post-transaction holdings by 8.0% to 26,874 shares. His prior trade history at ULBI shows strong 90-day timing outcomes—4 of 5 prior buys were well-timed, with median 90d returns of +22.7% to +28.5% when excluding the -1.9% outlier. The stock has moved +9.2% in the 30 days since filing and +21.1% in the 90-day window, aligning with his historical pattern of acquisitions preceding periods of price appreciation at this ticker. However, the company reports net income of -$1.2M in the latest quarter against revenue of $43.4M, and carries a P/E of 70.10, warranting evaluation of whether the near-term price action reflects sustainable fundamentals or momentum that may not hold.

CEO Michael Edward buys 2,000 shares at $4.97 avg while stock -24.6% in 30 days; ULBI down 44.6% from 52-week high.

Manna Michael Edward, as President and CEO, executed 2 separate purchases totaling 2,000 shares for $9,933.00 ($4.97 blended average) on 2025-11-19, increasing his holdings by 8.7% to 24.9K shares. The transaction occurred during significant recent weakness: the stock is -24.6% over the prior 30 days and -44.6% from its 52-week high of $9.13, trading at $5.06. His same-ticker history shows mixed timing: 3 of his 5 prior ULBI buys yielded positive 90-day returns, though the most recent buy on 2025-05-13 posted +48.0% in 30 days before this current decline; his cross-ticker track record across all holdings shows 60% win rate at the 90-day mark with +31.2% average return. The company faces headwinds: net income is -$1.2M on $43.4M revenue, P/E stands at 50.60, and YoY revenue growth is only +3.7%. The transaction is noteworthy as a significant open-market commitment by the company's top executive during a steep drawdown, though near-term price momentum remains negative.

ULBI: CEO Michael Manna bought 3.0K shares at $5.29, raising stake to 22.9K shares (+15.1%)

Michael Manna, President and CEO of Ultralife Corp, purchased 3,000 shares at $5.29 on 2025-05-13, increasing his holdings by 15.1% from 19.9K to 22.9K shares. The current stock price of $5.52 is 57.7% below the 52-week high of $13.06, and the stock has declined 23.9% over the past 90 days despite a +17.0% bounce in the last 30 days. At ULBI specifically, Manna's prior 4 trades show mixed timing: 2 of 4 buys achieved positive 90-day returns, suggesting a 50% success rate at this ticker. The company trades at a P/E of 17.25 with modest 3.7% annual revenue growth, and this purchase occurs as the stock rebounds modestly from recent lows but remains substantially depressed from year-ago valuation levels.

ULBI CEO Manna Michael Edward buys 1,500 shares at $7.24 as stock trades 44.8% below 52-week high

Manna Michael Edward, President and CEO, purchased 1,500 shares at $7.24 on 2024-11-21, expanding his holdings by 8.2% to 19.9K shares. This occurs while ULBI trades at $7.32 current price, which is -44.8% from the 52-week high of $13.25 and -17.8% over the past 30 days. His cross-ticker buy record shows 3 prior purchases with an average 90-day return of +43.1% and a 66.67% win rate, though at ULBI specifically his prior two 90-day outcomes were mixed (+22.7%, -3.2%, +110.0%), with 2 of 3 timely. The company shows underlying fundamentals including $35.7M quarterly revenue, +20.3% annual growth, and a 13.56 P/E ratio, providing context beyond the recent price weakness. The insider's willingness to add to his position during a pronounced drawdown and amid steep recent declines presents a discrete signal of continued engagement at current valuations.